Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy

Annals of Hematology

Volumn 89, Issue 7, 2010, Pages 701-713

  Kemp, Kevin ^d   Morse, Ruth ^a   Wexler, Sarah ^b   Cox, Christine ^b   Mallam, Elizabeth ^c   Hows, Jill ^a   Donaldson, Craig ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Bone marrow; Chemotherapy; Hematopoietic stem cells; Mesenchymal stem cells; Transplantation

Indexed keywords

ARABINOSIDE; ARSENIC TRIOXIDE; BUSULFAN; CARBOPLATIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOSINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HERMES ANTIGEN; HYDROXYUREA; IFOSFAMIDE; IMATINIB; INTERFERON; MELPHALAN; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PREDNISONE; RETINOIC ACID; RITUXIMAB; THALIDOMIDE; TIOGUANINE; UNINDEXED DRUG; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; BONE MARROW TOXICITY; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CELL DAMAGE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CRYOPRESERVATION; DRUG MEGADOSE; FEMALE; FLOW CYTOMETRY; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOPHENOTYPING; IN VITRO STUDY; LARGE CELL LYMPHOMA; MALE; MANTLE CELL LYMPHOMA; MESENCHYMAL STEM CELL; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MYELOMA; NONHODGKIN LYMPHOMA; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; THAWING; THROMBOCYTHEMIA; UMBILICAL CORD; BIOSYNTHESIS; BLOOD DISEASE; BONE MARROW CELL; CLINICAL TRIAL; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; STROMA CELL;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW CELLS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; STROMAL CELLS;

EID: 77953060677     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0896-2     Document Type: Article

References (42)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
2. Dexter TM, Spooncer E (1987) Growth and differentiation in the hemopoietic system. Annu Rev Cell Biol 3:423-441
3. Dexter TM, Allen TD, Lajtha LG (1977) Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91:335-344
4. Dexter TM, Spooncer E, Simmons P, Allen TD (1984) Long-term marrow culture: An overview of techniques and experience. Kroc Found Ser 18:57-96
5. Banfi A, Podesta M, Fazzuoli L, Sertoli MR, Venturini M, Santini G, Cancedda R, Quarto R (2001) High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: A mechanism for post-bone marrow transplantation osteopenia. Cancer 92:2419-2428
6. Carlo-Stella C, Tabilio A, Regazzi E, Garau D, La Tagliata R, Trasarti S, Andrizzi C, Vignetti M, Meloni G (1997) Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant 20:465-471
7. Cohen GI, Greenberger JS, Canellos GP (1982) Effect of chemotherapy and irradiation on interactions between stromal and hemopoietic cells in vitro. Scan Electron Microsc 359-365
8. Corazza F, Hermans C, Ferster A, Fondu P, Demulder A, Sariban E (2004) Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children. Pediatr Res 55:152-158
9. Domaratskaia EI, Bueverova EI, Paiushina OD, Starostin VI (2005) Alkylating damage by dipin of hematopoietic and stromal cells of the bone marrow. Izv Akad Nauk Ser Biol 267-272.
10. Galotto M, Berisso G, Delfino L, Podesta M, Ottaggio L, Dallorso S, Dufour C, Ferrara GB, Abbondandolo A, Dini G, Bacigalupo A, Cancedda R, Quarto R (1999) Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol 27:1460-1466
11. O'Flaherty E, Sparrow R, Szer J (1995) Bone marrow stromal function from patients after bone marrow transplantation. Bone Marrow Transplant 15:207-212
12. Domenech J, Gihana E, Dayan A, Truglio D, Linassier C, Desbois I, Lamagnere JP, Colombat P, Binet C (1994) Haemopoiesis of transplanted patients with autologous marrows assessed by longterm marrow culture. Br J Haematol 88:488-496
13. Domenech J, Roingeard F, Herault O, Truglio D, Desbois I, Colombat P, Binet C (1998) Changes in the functional capacity of marrow stromal cells after autologous bone marrow transplantation. Leuk Lymphoma 29:533-546 (Pubitemid 28288719)
14. Fried W, Chamberlin W, Kedo A, Barone J (1976) Effects of radiation on hematopoietic stroma. Exp Hematol 4:310-314
15. Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B (1987) Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 328:429-432
16. Cilloni D, Carlo-Stella C, Falzetti F, Sammarelli G, Regazzi E, Colla S, Rizzoli V, Aversa F, Martelli MF, Tabilio A (2000) Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood 96:3637-3643
17. Koc ON, Peters C, Aubourg P, Raghavan S, Dyhouse S, DeGasperi R, Kolodny EH, Yoseph YB, Gerson SL, Lazarus HM, Caplan AI, Watkins PA, Krivit W (1999) Bone marrowderived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol 27:1675-1681
18. Fibbe WE, Noort WA, Schipper F, Willemze R (2001) Ex vivo expansion and engraftment potential of cord blood-derived CD34 + cells in NOD/SCID mice. Ann N Y Acad Sci 938:9-17
19. Almeida-Porada G, Flake AW, Glimp HA, Zanjani ED (1999) Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol 27:1569-1575
20. Angelopoulou M, Novelli E, Grove JE, Rinder HM, Civin C, Cheng L, Krause DS (2003) Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 31:413-420
21. in 't Anker PS, Noort WA, Kruisselbrink AB, Scherjon SA, Beekhuizen W, Willemze R, Kanhai HH, Fibbe WE (2003) Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 31:881-889
22. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM (2000) Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18:307-316
23. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM (2003) Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121:368-374
24. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317
25. Hows JM, Bradley BA, Marsh JC, Luft T, Coutinho L, Testa NG, Dexter TM (1992) Growth of human umbilical-cord blood in long-term haemopoietic cultures. Lancet 340:73-76
26. Gee AP, Mansour V, Weiler M (1989) T-cell depletion of human bone marrow. J Immunogenet 16:103-115
27. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ (1999) Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107:275-281
28. Ishida T, Inaba M, Hisha H, Sugiura K, Adachi Y, Nagata N, Ogawa R, Good RA, Ikehara S (1994) Requirement of donorderived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol 152:3119-3127
29. Devine SM, Hoffman R (2000) Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol 7:358-363
30. Li J, Law HK, Lau YL, Chan GC (2004) Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol 127:326-334
31. Khaldoyanidi S, Sikora L, Orlovskaya I, Matrosova V, Kozlov V, Sriramarao P (2001) Correlation between nicotine-induced inhibition of hematopoiesis and decreased CD44 expression on bone marrow stromal cells. Blood 98:303-312
32. Moll J, Khaldoyanidi S, Sleeman JP, Achtnich M, Preuss I, Ponta H, Herrlich P (1998) Two different functions for CD44 proteins in human myelopoiesis. J Clin Invest 102:1024-1034
33. Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL (2000) Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9:841-848
34. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL (1998) Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 176:57-66
35. Reese JS, Koc ON, Gerson SL (1999) Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction. J Hematother Stem Cell Res 8:515-523
36. Muller-Sieburg CE, Deryugina E, Khaldoyanidi S, O'Rourke A (2000) Tissue- and epitope-specific mechanisms account for the diverse effects of anti-CD44 antibodies on the maintenance of primitive hematopoietic progenitors in vitro. Blood Cells Mol Dis 26:291-302
37. Khaldoyanidi S, Denzel A, Zoller M (1996) Requirement for CD44 in proliferation and homing of hematopoietic precursor cells. J Leukoc Biol 60:579-592
38. Miyake K, Medina KL, Hayashi S, Ono S, Hamaoka T, Kincade PW (1990) Monoclonal antibodies to Pgp-1/CD44 block lymphohemopoiesis in long-term bone marrow cultures. J Exp Med 171:477-488
39. Delfino DV, Patrene KD, DeLeo AB, DeLeo R, Herberman RB, Boggs SS (1994) Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow. J Immunol 152:5171-5179
40. de Wynter E, Ploemacher RE (2001) Assays for the assessment of human hematopoietic stem cells. J Biol Regul Homeost Agents 15:23-27
41. Zhao Z, Tang X, You Y, Li W, Liu F, Zou P (2006) Assessment of bone marrow mesenchymal stem cell biological characteristics and support hematopoiesis function in patients with chronic myeloid leukemia. Leuk Res 30:993-1003
42. Mueller LP, Luetzkendorf J, Mueller T, Reichelt K, Simon H, Schmoll HJ (2006) Presence of mesenchymal stem cells in human bone marrow after exposure to chemotherapy: Evidence of resistance to apoptosis induction. Stem Cells 24:2753-2765